Moved by
Lord Hunt of Kings Heath
66: After Clause 40, insert the following new Clause—
“Availability of medicines and medical devices for human use on the National Health Service
(1) The National Institute for Health and Care Excellence must have regard to the need—
(a) to address the implications of health inequalities when assessing the cost effectiveness of medicines and medical devices,
(b) to support early patient access to effective new medicines and medical devices, including by accepting a greater degree of uncertainty and risk in recommending their use,
(c) to ensure patients with rare diseases have access to medicines and medical devices that they need, and
(d) to support the use of curative therapies involving medicines and medical devices.
(2) The Secretary of State must lay a report and impact assessment before both Houses of Parliament setting out how the National Institute for Health and Care Excellence has implemented its duty under subsection (1), in particular in its manual on process and methods for developing NICE guidelines.”
Member’s explanatory statement
This new Clause would require the National Institute for Health and Care Excellence to ensure that its recommendations support the NHS in the ways described in subsection (1).